[Skip to Content]
[Skip to Content Landing]
Article
July 1986

Posterior Vitreous Fluorophotometry in Normal Subjects

Author Affiliations

From the Clinical Branch, Retinal and Vitreal Disease Section, National Eye Institute (Dr Roy and Ms Collier), the Biomedical Engineering and Instrumentation Branch, Division of Research Services (Drs Bonner and Bungay), and the Biometry and Epidemiology Program, National Eye Institute (Mr Podgor), National Institutes of Health, Bethesda, Md.

Arch Ophthalmol. 1986;104(7):1004-1008. doi:10.1001/archopht.1986.01050190062040
Abstract

• We performed vitreous fluorophotometry using the Fluorotron Master and intravenous fluorescein injection of 14 mg/kg of body weight in 22 normal subjects. Various methods of analysis were used to evaluate vitreous fluorescein concentration at 3 mm from the retina as well as averaged over the posterior 6 mm. The various methods of calculation yielded mean (±SD) postinjection values ranging from 1.7 ± 1.4 to 4.3 ± 2.3 ng/mL at 30 minutes and from 7.1 ± 2.4 to 10.8 ± 2.7 ng/mL at 60 minutes. The permeability index determined 60 minutes after injection ranged from 0.92 ± 0.40 × 10-7 to 1.19 ± 0.30 × 10-7 cm/s, according to the protocol used. Replicate pairs of measurements in six subjects demonstrated that the procedure was reproducible to within 17% to 49%, depending on the analysis. The results suggest that if the current methods of data analysis are used, fluorescein leakage might be considered abnormally high if at 60 minutes the 3-mm posterior vitreous fluorescein concentration corrected for background fluorescence exceeds 14.3 ng/mL and/ or the permeability index exceeds 2 × 10-7 cm/s.

References
1.
The Diabetic Retinopathy Study Research Group:  Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report No. 8 . Ophthalmology 1981;88:583-600.Article
2.
Oosterhuis JA, Vink R:  Fluorescein photography in diabetic retinopathy , in Crone RA, Henkef HE, Winkelman JE (eds): Perspectives in Ophthalmology . Amsterdam, Excerpta Medica, 1967, pp 115-132.
3.
Kohner EM, Dollery CT, Paterson JW, et al:  Arterial fluorescein studies in diabetic retinopathy . Diabetes 1967;16:1-10.
4.
Cunha-Vaz JG, Faria de Abreu JR, Campos AJ, et al:  Early breakdown of the blood retinal barrier in diabetes . Br J Ophthalmol 1975;59:649-656.Article
5.
Krupin T, Waltman SR, Oestrich C, et al:  Vitreous fluorophotometry in juvenile onset diabetes mellitus . Arch Ophthalmol 1978;96:812-814.Article
6.
Brooks AMV:  Experiences with fluorophotometry . Aust J Ophthalmol 1982;10:41-51.Article
7.
Kernell A, Larsson Y, Ludvigsson J, et al:  Vitreous fluorophotometry in juvenile diabetes . Acta Endocrinol 1980;94( (suppl 238) ):67-74.
8.
Cunha-Vaz JG, Gray JR, Zeimer RC, et al:  Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry . Diabetes 1985;34:53-59.Article
9.
Prager TC, Chu HH, Garcia CA, et al:  The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: Effect of vitreous abnormalities on the measurement . Invest Ophthalmol Vis Sci 1983;24:57-65.
10.
Bursell SE, Delori FC, Yoshida A, et al:  Vitreous fluorophotometric evaluation of diabetics . Invest Ophthalmol Vis Sci 1984;25:703-710.
11.
Krogsaa B, Lund-Andersen H, Mehlsen J, et al:  The blood retinal barrier permeability in diabetic patients . Acta Ophthalmol 1981;59:689-694.
12.
Conway B: Read before the Second Meeting of the International Society of Ocular Fluorophotometry, Sarasota, Fla, April 29, 1984.
13.
Kohner E: Read before the Second Meeting of the International Society of Ocular Fluorophotometry, Sarasota, Fla, April 29, 1984.
14.
Zeimer RC, Noth JM:  In vivo evaluation of signal loss due to lens opacity . Graefes Arch Clin Exp Ophthalmol 1985;222:221.Article
15.
Delori FC, Bursell SE, Yoshida A, et al:  Vitreous fluorophotometry in diabetics: Study of artifactual contributions . Graefes Arch Clin Exp Ophthalmol 1985;222:215-218.Article
16.
Prager TC, Chu HH, Garcia CA, et al:  The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: Effect of vitreous abnormalities on the measurement . Invest Ophthalmol Vis Sci 1983;24:57-65.
17.
Conway BP:  Technical variables in vitreous fluorophotometry . Graefes Arch Clin Exp Ophthalmol 1985;222:194-201.Article
18.
Klein R, Ernest JT:  Fluorophotometry I technique . Arch Ophthalmol 1980;98:2231-2232.Article
19.
Prager TC, Wilson DJ, Avery GD:  Vitreous fluorophotometry: Identification of sources of variability . Invest Ophthalmol Vis Sci 1981; 21:854-864.
20.
Zeimer RC, Cunha-Vaz JG, Johnson ME:  Studies on the technique of vitreous fluorophotometry . Invest Ophthalmol Vis Sci 1982;22:668-674.
21.
Zeimer RC, Blair NP, Cunha-Vaz JG:  Vitreous fluorophotometry for clinical research: I. Description and evaluation of a new fluorophotometer . Arch Ophthalmol 1983;101:1753-1756.Article
22.
Zeimer RC, Blair NP, Cunha-Vaz JG:  Vitreous fluorophotometry for clinical reserach: II. Method of data acquisition and processing . Arch Ophthalmol 1983;101:1757-1761.Article
23.
McCullough PC, Koester CJ, Campbell CJ, et al:  An evaluation of the clinical role of vitreous fluorophotometry . Trans Am Ophthalmol Soc 1983;81:130-148.
24.
Chahal PS, Chowienczyk PJ, Kohner EM:  Measurement of blood retinal barrier permeability: A reproducibility study in normal eyes . Invest Ophthalmol Vis Sci 1985;25:977-982.
25.
Ogura Y, Tsukahara Y, Saito I, et al:  Estimation of the permeability of the blood retinal barrier in normal individuals . Invest Ophthalmol Vis Sci 1985;26:969-976.
26.
Cunha-Vaz JG:  Protocols for the vitreous fluorophotometry examination: A general plan . Graefes Arch Clin Exp Ophthalmol 1985;222:220.Article
27.
Araie M, Sawa J, Nagataki S, et al:  Aqueous humor dynamics in man as studied by oral fluorescein . Jpn J Ophthalmol 1980;24:346-362.
28.
Lund-Andersen H, Krogsaa B, La Cour M, et al:  Quantitative vitreous fluorophotometry applying a mathematical model of the eye . Invest Ophthalmol Vis Sci 1985;26:698-710.
29.
Grayson MC, Laties AM:  Ocular localization of sodium fluorescein . Arch Ophthalmol 1971;85:600-609.Article
30.
Grimes PA, Stone RA, Laties AM:  Carboxyfluorescein: A probe of the blood ocular barriers with lower membrane permeability than fluorescein . Arch Ophthalmol 1982;100:635-639.Article
31.
Cunha-Vaz JG, Zeimer R, Wong WP, et al:  Kinetic vitreous fluorophotometry in normals and non-insulin-dependent diabetics . Ophthalmology 1982;89:751-756.Article
32.
Dixon WJ, Massey FJ: Introduction to Statistical Analysis . New York, McGraw-Hill International Book Co, 1951, pp 110-111.
33.
Chen SC, Nakamura H, Tamura Z:  Studies on the metabolites of fluorescein in rabbit and human urine . Chem Pharm Bull 1980;28:1403-1407.Article
34.
Chen SC, Nakamura H, Tamura Z:  Determination of fluorescein and fluorescein monoglucuronide excreted in urine . Chem Pharm Bull 1980;28:2812-2816.Article
35.
Smith RT, Koester CJ, Cadenas CH, et al:  Vitreous fluorophotometry data analysis by deconvolution . Invest Ophthalmol Vis Sci 1984;25( (suppl) ):255.
×